Plain Language Summaries
Bibliographic record
Abstract
Psoriasis is a common skin disease affecting about 2% of the population.In about 90% of cases it requires long-term treatment.For this reason, treatments which have been proved safe and efficient during long-term trials are required.Such treatments for patients with severe psoriasis include biologics (biological drugsso named because they mimic normal human molecules).There are several different types of biologics and this study demonstrates that while these treatments have individually been shown to be effective and safe, it is difficult to make direct comparisons between the different versions.This is because there is variance in the way the clinical trials (a type of research using real patients) are designed and how the data is analyzed in different studies.The range of variables outlined includes missing data, caused when patients taking part in the trial drop out, stop using the drug or miss assessments, which can bias results.There are four standard strategies for addressing the problem of missing data, and the authors, from Canada and Germany, show how results from a real clinical study changed when the different methods were used.The authors then evaluated the results of existing clinical trials, taking into account the different choices for designing clinical trials and analyzing the data, to determine how these choices may influence how the overall outcomes should be interpreted.They conclude that in the absence of common standards for long-term trials, doctors need to understand the differences in handling data so that they can better compare different therapies, in order to make the best choices for patients.Narrowband ultraviolet B (NBUVB) phototherapy in children with moderate to severe eczemaa comparative cohort study S.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.052 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.005 | 0.005 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.005 | 0.004 |
| Open science | 0.002 | 0.002 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.772 | 0.648 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".